Found: 31
Select item for more details and to access through your institution.
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer.
- Published in:
- Basic & Clinical Andrology, 2018, v. 28, n. 1, p. N.PAG, doi. 10.1186/s12610-018-0074-2
- By:
- Publication type:
- Article
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy.
- Published in:
- Kidney International, 2003, v. 63, n. 1, p. 306, doi. 10.1046/j.1523-1755.2003.00714.x
- By:
- Publication type:
- Article
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 3, p. 416, doi. 10.1007/s10147-022-02283-w
- By:
- Publication type:
- Article
Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 2, p. 289, doi. 10.1007/s10147-022-02256-z
- By:
- Publication type:
- Article
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 154, doi. 10.1007/s10147-021-02014-7
- By:
- Publication type:
- Article
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 3, p. 486, doi. 10.1007/s10147-019-01554-3
- By:
- Publication type:
- Article
Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer.
- Published in:
- Molecular & Clinical Oncology, 2018, v. 8, n. 6, p. 791, doi. 10.3892/mco.2018.1614
- By:
- Publication type:
- Article
Steroid sulfatase promotes invasion through epithelial-mesenchymal transition and predicts the progression of bladder cancer.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 16, n. 6, p. 4463, doi. 10.3892/etm.2018.6787
- By:
- Publication type:
- Article
Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 11, p. 444, doi. 10.3390/jcm7110444
- By:
- Publication type:
- Article
PRIMARY UROTHELIAL CARCINOMA WITH SARCOMATOUS TRANSFORMATION OF THE PROSTATE.
- Published in:
- Japanese Journal of Urology / Nihon Hinyokika Gakkai Zasshi, 2010, v. 101, n. 5, p. 698
- By:
- Publication type:
- Article
Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in Japan.
- Published in:
- BMC Urology, 2011, v. 11, n. 1, p. 11, doi. 10.1186/1471-2490-11-11
- By:
- Publication type:
- Article
Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells.
- Published in:
- Cancer Science, 2017, v. 108, n. 9, p. 1820, doi. 10.1111/cas.13318
- By:
- Publication type:
- Article
Carbonic anhydrase 2 is a novel invasion-associated factor in urinary bladder cancers.
- Published in:
- Cancer Science, 2017, v. 108, n. 3, p. 331, doi. 10.1111/cas.13143
- By:
- Publication type:
- Article
Anti-PD-L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1736, doi. 10.1111/cas.13099
- By:
- Publication type:
- Article
DDX39 acts as a suppressor of invasion for bladder cancer.
- Published in:
- Cancer Science, 2012, v. 103, n. 7, p. 1363, doi. 10.1111/j.1349-7006.2012.02298.x
- By:
- Publication type:
- Article
Kamikihito improves cancer‐related fatigue in castration‐resistant prostate cancer patients receiving enzalutamide: Multidimensional approach including metabolomics analysis.
- Published in:
- Traditional & Kampo Medicine, 2021, v. 8, n. 3, p. 204, doi. 10.1002/tkm2.1298
- By:
- Publication type:
- Article
Lenvatinib plus pembrolizumab versus sunitinib for advanced renal cell carcinoma: Japanese patients from the CLEAR study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6902, doi. 10.1002/cam4.5483
- By:
- Publication type:
- Article
Phase I/II study of multipeptide cancer vaccine IMA901 after single‐dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long‐term follow up.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 2, p. 176, doi. 10.1111/iju.15077
- By:
- Publication type:
- Article
Editorial Comment to Efficacy and safety of first‐line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.
- Published in:
- International Journal of Urology, 2020, v. 27, n. 12, p. 1100, doi. 10.1111/iju.14383
- By:
- Publication type:
- Article
Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.
- Published in:
- International Journal of Urology, 2020, v. 27, n. 11, p. 952, doi. 10.1111/iju.14329
- By:
- Publication type:
- Article
Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 3, p. 258, doi. 10.1111/iju.13500
- By:
- Publication type:
- Article
Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.
- Published in:
- BJU International, 2014, v. 113, n. 2, p. 320, doi. 10.1111/bju.12499
- By:
- Publication type:
- Article
Treatment outcomes of ureteral stenting for malignant extrinsic ureteral obstruction: a comparison between polymeric and metallic stents.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 2977, doi. 10.2147/CMAR.S172283
- By:
- Publication type:
- Article
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 848, doi. 10.1007/s10147-019-01413-1
- By:
- Publication type:
- Article
Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 5, p. 944, doi. 10.1007/s10147-018-1288-1
- By:
- Publication type:
- Article
Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 790, doi. 10.1007/s10147-014-0764-5
- By:
- Publication type:
- Article
Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study.
- Published in:
- World Journal of Urology, 2015, v. 33, n. 5, p. 659, doi. 10.1007/s00345-014-1399-x
- By:
- Publication type:
- Article
Palliative Treatment of Bone Metastases in Hormone-Refractory Prostate Cancer: Effects of Pamidronate on the Carboxyterminal Telopeptide of Type-I Collagen Level in Patients with Increasing Prostate-Specific Antigen Levels.
- Published in:
- Urologia Internationalis, 2007, v. 78, n. 4, p. 345, doi. 10.1159/000100840
- By:
- Publication type:
- Article
Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: Comparison of morning and evening dosing.
- Published in:
- International Journal of Urology, 2015, v. 22, n. 3, p. 317, doi. 10.1111/iju.12669
- By:
- Publication type:
- Article
Association of MnSOD AA Genotype with the Progression of Prostate Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131325
- By:
- Publication type:
- Article
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study).
- Published in:
- 2019
- By:
- Publication type:
- journal article